187 related articles for article (PubMed ID: 25557247)
1. PINK1 phosphorylates transglutaminase 2 and blocks its proteasomal degradation.
Min B; Kwon YC; Choe KM; Chung KC
J Neurosci Res; 2015 May; 93(5):722-35. PubMed ID: 25557247
[TBL] [Abstract][Full Text] [Related]
2. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
3. CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
Min B; Park H; Lee S; Li Y; Choi JM; Lee JY; Kim J; Choi YD; Kwon YG; Lee HW; Bae SC; Yun CO; Chung KC
Oncogene; 2016 Jul; 35(28):3718-28. PubMed ID: 26568304
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
5. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress.
Muqit MM; Abou-Sleiman PM; Saurin AT; Harvey K; Gandhi S; Deas E; Eaton S; Payne Smith MD; Venner K; Matilla A; Healy DG; Gilks WP; Lees AJ; Holton J; Revesz T; Parker PJ; Harvey RJ; Wood NW; Latchman DS
J Neurochem; 2006 Jul; 98(1):156-69. PubMed ID: 16805805
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
Strnad P; Harada M; Siegel M; Terkeltaub RA; Graham RM; Khosla C; Omary MB
Gastroenterology; 2007 Apr; 132(4):1515-26. PubMed ID: 17408647
[TBL] [Abstract][Full Text] [Related]
7. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
[TBL] [Abstract][Full Text] [Related]
8. The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.
Altuntas S; Rossin F; Marsella C; D'Eletto M; Diaz-Hidalgo L; Farrace MG; Campanella M; Antonioli M; Fimia GM; Piacentini M
Oncotarget; 2015 Dec; 6(42):44941-54. PubMed ID: 26702927
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.
Park D; Choi SS; Ha KS
Amino Acids; 2010 Aug; 39(3):619-31. PubMed ID: 20148342
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial impairment increases FL-PINK1 levels by calcium-dependent gene expression.
Gómez-Sánchez R; Gegg ME; Bravo-San Pedro JM; Niso-Santano M; Alvarez-Erviti L; Pizarro-Estrella E; Gutiérrez-Martín Y; Alvarez-Barrientos A; Fuentes JM; González-Polo RA; Schapira AH
Neurobiol Dis; 2014 Feb; 62():426-40. PubMed ID: 24184327
[TBL] [Abstract][Full Text] [Related]
11. Loss of PINK1 function decreases PP2A activity and promotes autophagy in dopaminergic cells and a murine model.
Qi Z; Yang W; Liu Y; Cui T; Gao H; Duan C; Lu L; Zhao C; Zhao H; Yang H
Neurochem Int; 2011 Oct; 59(5):572-81. PubMed ID: 21672589
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1.
Takatori S; Ito G; Iwatsubo T
Neurosci Lett; 2008 Jan; 430(1):13-7. PubMed ID: 18031932
[TBL] [Abstract][Full Text] [Related]
13. L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.
Moriwaki Y; Kim YJ; Ido Y; Misawa H; Kawashima K; Endo S; Takahashi R
Neurosci Res; 2008 May; 61(1):43-8. PubMed ID: 18359116
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin E3 ligase CHIP promotes proteasomal degradation of the serine/threonine protein kinase PINK1 during staurosporine-induced cell death.
Yoo L; Chung KC
J Biol Chem; 2018 Jan; 293(4):1286-1297. PubMed ID: 29242192
[TBL] [Abstract][Full Text] [Related]
15. Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity.
Ha HJ; Kwon S; Jeong EM; Kim CM; Lee KB; Kim IG; Park HH
PLoS One; 2018; 13(10):e0204707. PubMed ID: 30321187
[TBL] [Abstract][Full Text] [Related]
16. Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.
Liu C; Wang W; Parchim N; Irani RA; Blackwell SC; Sibai B; Jin J; Kellems RE; Xia Y
Hypertension; 2014 Feb; 63(2):353-61. PubMed ID: 24191290
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
18. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
Sim CH; Lio DS; Mok SS; Masters CL; Hill AF; Culvenor JG; Cheng HC
Hum Mol Genet; 2006 Nov; 15(21):3251-62. PubMed ID: 17000703
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibition promotes mono-ubiquitination and nuclear translocation of mature (52 kDa) PINK1.
Sun L; Büeler H
Biochem Biophys Res Commun; 2019 Sep; 517(2):376-382. PubMed ID: 31362890
[TBL] [Abstract][Full Text] [Related]
20. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
Johnson KA; Terkeltaub RA
J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
